The Scientific Program Committee welcomes the submission of abstracts for presentation at the 2020 Joint ACTRIMS-ECTRIMS Meeting.
|Tuesday, February 4, 2020||Abstract Submission opens|
|Tuesday, May 26, 2020||Abstract Submission closes|
|Wednesday, May 27, 2020||Late Breaking Abstract Submission opens|
|Monday, July 6, 2020||Notification of acceptance or rejection of Regular Abstracts|
|Tuesday, July 7, 2020||Late Breaking Abstract Submission closes|
|Friday, July 31, 2020||Notification of acceptance or rejection of Late Breaking Abstracts|
|Friday, August 28, 2020||Accepted Regular Abstracts published|
|Wednesday, September 9, 2020||Accepted Late Breaking Abstracts published|
UPDATE: With other international meetings forced to cancel due to COVID-19, MSWashingtonDC2020 will consider abstracts that contain material published by a cancelled meeting but not presented (e.g. AAN’s publication of abstracts from their cancelled 2020 Annual Meeting). Please note that we do still encourage abstracts that contain original material not published at the time of submission.
After you submit your abstract, you will receive a confirmation email with your abstract number. If you do not receive an email confirmation within 24 hours, please contact Online Support at email@example.com. Should you wish to make corrections to an abstract already submitted, you may login to your account via the abstract submission site. Corrections to abstracts can be made up to the abstract submission deadline of Tuesday, May 26, 2020, 23:59 ET for Regular Abstracts and Tuesday, July 7, 2020, 23:59 ET for Late Breaking Abstracts.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Interstate Postgraduate Medical Association (IPMA) and ACTRIMS-ECTRIMS. IPMA is accredited by the ACCME to provide continuing medical education (CME) for physicians.
IPMA will designate the Oral Presentations for CME credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The rules governing eligibility of scientific meetings for CME are complicated and continually evolving, in particular the rules related to submissions involving commercial interests (as defined by the ACCME). Please note the following policies concerning abstracts for this meeting, some of which may differ from those of other scientific meetings you may have attended.
Abstracts accepted for Oral Presentations, for which CME credits will be offered, will be designated as such and will be clearly distinguished from non-CME work. For your submission to be included in a plenary session that meets the requirements for AMA Category I credit and adheres to ACCME guidelines, it must meet each of the following criteria:
CME will not be offered for the poster sessions.
Abstracts with authors who are employees of commercial interests, including abstracts solely from commercial interests, will be considered for non-CME Sessions or Poster Sessions.
Abstracts reporting results from collaborative research conducted by both independent investigators (academic, clinician and/or scientist) and investigators who are employees of commercial interests will not be accepted unless the independent investigators are included as authors.
Each abstract will be reviewed by 3-4 external experts. Each reviewer will receive the author(s) name(s) and affiliation along with the abstract. Upon completion of the external review, the final decision of acceptance or rejection will be made by the Congress Planning Committee.
The presenting author of an accepted abstract must register and attend MSWashingtonDC2020.
All presenters are responsible for their own registration, accommodation and travel expenses. If you are a non-U.S. citizen, don’t delay in applying for a visa for entry into the United States, if one is needed. Such arrangements are the responsibility of conference attendees. For more information on Visa Requirements, please visit the General Information page.
Full instructions concerning Poster and/or Oral Presentation of accepted abstracts will be included in the notification letter and available on the MSWashingtonDC2020 website.
All accepted abstracts will be published in the Multiple Sclerosis Journal Online and may also be viewed on the MSWashingtonDC2020 online program and mobile app.
Full text of Regular Abstracts will be published on Friday, August 28, 2020. Full text of Late Breaking Abstracts will be published on the first day of the meeting (Wednesday, September 9, 2020).
Posters and slides of accepted presentations will be posted on the MSWashingtonDC2020 online program and mobile app during and after the meeting.
If you do not wish to have your poster or slides on the online program or mobile app, please indicate as such when you submit your materials.
Late Breaking Abstract submission will open on Wednesday, May 27, 2020, and close Tuesday, July 7, 2020. The process for submitting Late Breaking Abstracts will be similar to that of Regular Abstracts (see Preparation of Abstracts above).
A select number of Late Breaking Abstracts will be accepted for Oral Presentation during the Late Breaking News Session on Saturday, September 12, 2020. The remaining accepted abstracts will be presented as posters.
Notification of acceptance or rejection of submitted Late Breaking Abstracts will be sent to the corresponding presenting authors via email by Friday, July 31, 2020. Full instructions concerning Poster and/or Oral Presentation of accepted abstracts will be included and available on the MSWashingtonDC2020 website.
During the abstract submission process, a primary keyword (or topic) must be selected that best fits your submission. You will be able to select from the following keywords:
Presenting authors who are trainees, or who have obtained an advanced degree (M.D. or Ph.D.) within seven years of the time of submission, are considered a Young Investigator. Abstracts from Young Investigators will be considered for an Oral Presentation during the Young Investigator Sessions. Candidates may be students, residents, postdoctoral fellows or junior faculty. If there are extenuating circumstances that may qualify you to be considered a Young Investigator, please contact firstname.lastname@example.org. Final decisions regarding eligibility will be made by the Scientific Program Committee.
If you wish to be considered a Young Investigator, be sure to indicate as such during the abstract submission process. You may be contacted for proof of eligibility if your abstract is selected for an Oral Presentation.
For information on Educational Grants and Young Investigator Awards, please visit the Grants & Awards page.
For more information on the program, support opportunities or any general questions, please contact:
+ 1 608 310 8960
1818 Parmenter Street, Suite 300
Middleton, Wisconsin 53562
WARNING: There are an increasing number of misleading websites that impersonate MSDC2020. Please be aware of possible scams and note the official congress website is www.msdc2020.org.
For more information on registration and housing, please contact:
+ 1 604 681 2153
+ 1 604 681 2153
GROUP REGISTRATION AND HOUSING
+1 604 681 2153
International Conference Services
Suite 300, 1201 West Pender Street
Vancouver, BC, Canada V6E 2V2
We look forward to connecting soon.Click here to close this window